ʻO Kina Velpatasvir(PVP) nā mea hana a me nā mea hoʻolako

Velpatasvir(PVP)

ʻO ka wehewehe pōkole:

Ka inoa o ka API	Hōʻike	Hōʻike	US DMF	EU DMF	CEP
Velpatasvir(PVP)	HCV	I-Hale	√

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

NUI HUA

Na Inoa Haole

Velpatasvirus (Latina)

Velpatasvir (Kelemānia)

Velpatasvir (Palani)

Velpatasvir (Papania)

Nā inoa maʻamau

Velpatasvir (OS: USAN)

GS-5816 (IS)

UNII-KCU0C7RS7Z (IS)

ʻO nā lāʻau lapaʻau hoʻohuihui ʻia me ka velpatasvir: sofosbuvir/velpatasvir systemic

Nā inoa inoa: Epclusa
Papa lāʻau (es): hui pū ʻia antiviral
Hoʻohana ʻia ʻo Sofosbuvir/velpatasvir systemic i ka mālama ʻana i: Hepatitis C

sofosbuvir/velpatasvir/voxilaprevir systemic

Nā inoa inoa: Vosevi
Papa lāʻau (es): hui pū ʻia antiviral
Hoʻohana ʻia ʻo Sofosbuvir/velpatasvir/voxilaprevir systemic i ka mālama ʻana i: Hepatitis C

维帕他韦	Velpatasvir	1377049-84-7	I-Hale
VLPM1		334769-80-1	I-Hale
VLPM2		1378388-16-9	I-Hale
VLP-5-Br		1438383-89-1	I-Hale
VLP-5		1378390-29-4	I-Hale
VLP-10		1378391-45-7	I-Hale

Na Waiwai Kemika

Waihona	E mālama i ka -20°C
M.Wt	883.0
Cas No.	1377049-84-7
Kumukumu	C49H54N8O8
Nā huaʻōlelo like	GS-5816
Ka hoʻoheheʻe	≥146.66mg/mL i DMSO (Pono ultrasonic a me ka hoʻomehana); ʻAʻole hiki ke hoʻoheheʻe ʻia i ka H2O
SDF	Hoʻoiho iā SDF
KANAKA MANAKA	O=C(N1C[C@@H](COC)C[C@H]1C2=NC=C(C3=CC=C(C(C=C(C=CC4=C5N=C([C@H) ]6N(C([C@H](C(C )C)NC(OC)=O)=O)[C@@H](C)CC6)N4)C5=C7)=C7OC8)C8=C3)N2)[C@H](NC(OC)= O)C9=CC=CC=C9
Kūlana Hoʻouna	Haʻina hāpana loiloi: moku me ka hau polū. Loaʻa nā nui ʻē aʻe: moku me RT, a i ʻole hau polū ma ke noi.
Nā ʻōlelo aʻoaʻo maʻamau	No ka loaʻa ʻana o kahi solubility kiʻekiʻe, e ʻoluʻolu e hoʻomaʻamaʻa i ka paipu ma 37 ° C a lulu i loko o ka ʻauʻau ultrasonic no kekahi manawa. Hiki ke mālama ʻia ka hoʻonā waiwai ma lalo o -20°C no kekahi mau mahina.